PeterMD review
Both molecules have a cancel-anytime monthly product, while the tirzepatide landing page leads with a quarterly plan.
The verdict
PeterMD publishes $270 a month for compounded semaglutide, struck from $417, with medicine included and the same price at every dose. Month-to-month tirzepatide is $299, and the $249 on its landing page is billed quarterly.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- States
- 42
- From
- From $270/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Availability
- 42 states
PeterMD sells both molecules by injection across 42 states, each as a month-to-month subscription, with a quarterly tirzepatide plan offered beside the monthly one.
Who writes the prescription, and what do they see?
A prescription precedes shipping and the clinician is not described. What the pages do describe is a subscription that can be canceled at any time, which is a term rather than a clinical fact.
The useful disclosures here are real: medicine included, the same price at every dose, cancel anytime. The tirzepatide landing page is the exception, since its lead figure is a start charge followed by a quarterly bill, and the monthly product sits on a separate page.
What happens when the dose goes up?
The semaglutide line is stated to cost the same at every dose, which answers the question directly. The quarterly tirzepatide plan names a 60 mg supply, and the pages say the period the medication lasts depends on the dose prescribed, so a quarter's supply covers a shorter span at a higher dose.
What the price includes
The month-to-month semaglutide figure is $270 and six months is $1,620. Month-to-month tirzepatide is $299, or $1,794 over six months. The tirzepatide landing page offers $149 to start and then $249 a month billed quarterly, which is cheaper only for a buyer ready to pay three months at a time.
What it claims, and what it cites
Both lines are compounded rather than manufactured, prepared by a pharmacy the site does not name, and not reviewed by the FDA before dispensing as an approved product is.
Where it holds up, and where it does not
- Strength: Same price at every dose, stated
- Strength: Medicine included in the figure
- Strength: Cancel anytime on the subscriptions
- Strength: Coverage recorded across 42 states
- Limitation: The tirzepatide landing page leads with a quarterly plan
- Limitation: The monthly tirzepatide product sits on a separate page
- Limitation: A quarterly supply's span depends on the dose
- Limitation: Eight states are not served
What the evidence says about this kind of treatment
The assessment above is about PeterMD. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who wants a cancel-anytime subscription on either molecule.
- Wrong for
- A reader planning from the tirzepatide landing page's $149 start figure.
The evidence behind what PeterMD prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How PeterMD compares
| Seller | Who it suits | Go |
|---|---|---|
 PlexusDx | A reader who will scroll past the entry card to find a product with a name | See PlexusDx → |
 Ozari Health | A reader new to the drug class who will check the plan table before quarter two | See Ozari Health → |
 Oria Meds | Readers who will commit six months and know which rung the headline is | See Oria Meds → |
More GLP-1 telehealth sellers reviews: SipraSommar ClubStaveMDSteady State HealthSuper Healthy RxTablet Health
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Is the $149 tirzepatide start the monthly price?
- No. It is the first charge, followed by $249 a month billed quarterly. Month-to-month tirzepatide is a separate product at $299.
- Does the semaglutide price rise with the dose?
- No. The subscription is stated as the same price at every dose, with medicine included.
- What does a month actually cost?
- $270 for semaglutide month to month and $299 for tirzepatide, each cancelable at any time.
- Is PeterMD legit?
- PeterMD is a GLP-1 telehealth sellers service. Its stated availability: 42 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is PeterMD expensive compared with other GLP-1 telehealth sellers?
- PeterMD publishes a starting figure of $270/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts PeterMD above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.